ATE62815T1 - Entzuendungshemmende creme. - Google Patents

Entzuendungshemmende creme.

Info

Publication number: ATE62815T1
Authority: AT; Austria
Prior art keywords: alpha; inflammatory cream; furoate; inflammatory; cream
Prior art date: 1986-10-02

Application number

AT87114368T

Other languages

English (en)

Inventor

Farah Joseph Munayyer

Joel August Sequeira

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-10-02

Filing date

1987-10-01

Publication date

1991-05-15

1987-10-01 Application filed by Schering Corp filed Critical Schering Corp

1991-05-15 Application granted granted Critical

1991-05-15 Publication of ATE62815T1 publication Critical patent/ATE62815T1/de

Links

230000003110 anti-inflammatory effect Effects 0.000 title abstract 2
239000006071 cream Substances 0.000 title abstract 2
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229960002744 mometasone furoate Drugs 0.000 abstract 1
WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Peptides Or Proteins (AREA)
Semiconductor Memories (AREA)
Insulated Gate Type Field-Effect Transistor (AREA)

AT87114368T 1986-10-02 1987-10-01 Entzuendungshemmende creme. ATE62815T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/914,227 US4808610A (en)	1986-10-02	1986-10-02	Mometasone furoate anti-inflammatory cream composition using hexylene glycol

Publications (1)

Publication Number	Publication Date
ATE62815T1 true ATE62815T1 (de)	1991-05-15

Family

ID=25434063

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT87114368T ATE62815T1 (de)	1986-10-02	1987-10-01	Entzuendungshemmende creme.

Country Status (22)

Country	Link
US (1)	US4808610A (de)
EP (2)	EP0262681B1 (de)
JP (1)	JPH0643317B2 (de)
KR (2)	KR930010585B1 (de)
AT (1)	ATE62815T1 (de)
AU (1)	AU603837B2 (de)
CA (1)	CA1294877C (de)
DE (1)	DE3769568D1 (de)
DK (1)	DK174790B1 (de)
ES (1)	ES2038643T3 (de)
FI (1)	FI100047B (de)
GR (1)	GR3002086T3 (de)
HK (1)	HK102593A (de)
IE (1)	IE60492B1 (de)
IL (1)	IL84055A (de)
MX (1)	MX9203395A (de)
NO (1)	NO175350C (de)
NZ (1)	NZ222020A (de)
OA (1)	OA09034A (de)
PH (1)	PH23440A (de)
WO (1)	WO1988002257A1 (de)
ZA (1)	ZA877401B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0309353B1 (de) *	1987-09-23	1994-07-27	L'oreal	Hautbehandlungsmittel als Aerosolschaum, das Vaseline enthält
US5223340A (en) *	1989-04-20	1993-06-29	Peach State Labs, Inc.	Stain resistant polyamide fibers
US5057500A (en) *	1990-02-12	1991-10-15	Dermatologic Research Corporation	Treatment of pruritis with esters and amides
JPH0725789B2 (ja) *	1990-09-10	1995-03-22	シェリング・コーポレーション	フランカルボン酸モメタゾン―水和物、その製造法および医薬組成物
US6127353A (en) *	1991-09-06	2000-10-03	Schering Corporation	Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
US5407678A (en) *	1993-09-01	1995-04-18	Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.	Petroleum jelly cream
NZ278198A (en) *	1993-12-21	1997-12-19	Schering Corp	Pharmaceutical compositions comprising mometasone furoate and salicyclic acid; use in treatment of psoriasis
US5696105A (en) *	1996-03-14	1997-12-09	Hackler; Walter A.	Antifungal nail composition
US6495579B1 (en)	1996-12-02	2002-12-17	Angiotech Pharmaceuticals, Inc.	Method for treating multiple sclerosis
US6515016B2 (en) *	1996-12-02	2003-02-04	Angiotech Pharmaceuticals, Inc.	Composition and methods of paclitaxel for treating psoriasis
JP4101464B2 (ja) *	1998-08-26	2008-06-18	塩野義製薬株式会社	抗炎症軟膏剤
FR2787025B1 (fr) *	1998-12-14	2002-10-11	Oreal	Composition sous forme d'emulsion h/e a forte teneur en cire et ses utilisations dans les domaines cosmetique et dermatologique
KR20040077813A (ko)	2002-02-19	2004-09-06	호야 가부시키가이샤	전계효과트랜지스터형 발광소자
US7312207B2 (en)	2003-05-23	2007-12-25	Taro Pharmaceuticals North America, Inc.	Topical steroid cream formulations
DE102006034883A1 (de) *	2006-07-25	2008-01-31	Hermal Kurt Herrmann Gmbh & Co. Ohg	Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
EP2120868A4 (de) *	2007-04-11	2010-08-25	Perrigo Israel Phamaceuticals	Niedrigdosierte mometason-formulierungen
US20080311058A1 (en) *	2007-06-18	2008-12-18	Connopco, Inc., D/B/A Unilever	Stable high internal phase emulsions and compositions comprising the same
MX2010002592A (es) *	2007-09-10	2010-03-30	Glenmark Pharmaceuticals Ltd	Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides.
US20090082318A1 (en) *	2007-09-26	2009-03-26	Protia, Llc	Deuterium-enriched mometasone
AU2009310634B2 (en) *	2008-10-30	2013-05-09	Ego Pharmaceuticals Pty Ltd	Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water
RU2396081C1 (ru) *	2008-12-29	2010-08-10	Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН")	Фармацевтическая композиция для лечения дерматозов, поддающихся глюкокортикостероидной терапии, и способ ее получения
BRPI1010907B8 (pt)	2009-05-12	2021-05-25	Galenica Ab	emulsão de óleo-em-água de mometasona e propileno-glicol
EP2394653A1 (de)	2010-05-26	2011-12-14	Almirall, S.A.	Topische pharmazeutische Zusammensetzungen enthaltend Mometasonfuroat
US20110305649A1 (en) *	2010-06-14	2011-12-15	Conopco, Inc., D/B/A Unilever	High Humectant High Internal Phase Emulsion
US8821839B2 (en)	2010-10-22	2014-09-02	Conopco, Inc.	Compositions and methods for imparting a sunless tan with a vicinal diamine
US8398959B2 (en)	2010-12-06	2013-03-19	Conopco, Inc.	Compositions and methods for imparting a sunless tan with functionalized adjuvants
US8961942B2 (en)	2011-12-13	2015-02-24	Conopco, Inc.	Sunless tanning compositions with adjuvants comprising sulfur comprising moieties
RU2548764C2 (ru) *	2013-01-25	2015-04-20	Открытое Акционерное Общество "Татхимфармпрепараты"	Лекарственное средство для лечения дерматозов (варианты)
US9744122B2 (en) *	2013-04-29	2017-08-29	Helene Bertrand	Topical formulation for pain relief
JP2015196663A (ja) *	2014-04-01	2015-11-09	ロレアル	ナノ又はマイクロエマルションの形態の組成物
FR3039399B1 (fr) *	2015-07-31	2018-08-24	Idl International Drug Licensing	Creme pour l'admnistration de steroides et son procede de preparation
MX2023002086A (es) *	2020-08-20	2023-03-15	Pfizer	Formulaciones topicas estables de 1(r)-4-(5-(4-metoxi-3-propoxifen il)piridin-3-il)-1,2-oxaborolan-2-ol.
JP2026501094A (ja)	2022-12-20	2026-01-14	ガレニカデルマエービー	局所的皮膚処置のための新規な組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4048310A (en) *	1976-02-24	1977-09-13	E. R. Squibb & Sons, Inc.	Topical steroid formulation in form of lotion or cream
US4070462A (en) *	1976-10-26	1978-01-24	Schering Corporation	Steroid ointment
US4124707A (en) *	1976-12-22	1978-11-07	Schering Corporation	7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor
US4083974A (en) *	1977-03-07	1978-04-11	The Upjohn Company	Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
US4201778A (en) *	1977-11-08	1980-05-06	Schering Corporation	6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates
US4267173A (en) *	1979-11-05	1981-05-12	Schering Corporation	Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
CY1359A (en) *	1981-02-02	1987-08-07	Schering Corp	Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
JPS59137408A (ja) *	1983-01-27	1984-08-07	Taisho Pharmaceut Co Ltd	軟膏
US4489071A (en) *	1983-12-09	1984-12-18	Schering Corporation	Betamethasone dipropionate cream

1986
- 1986-10-02 US US06/914,227 patent/US4808610A/en not_active Expired - Lifetime
1987
- 1987-10-01 EP EP87114368A patent/EP0262681B1/de not_active Expired - Lifetime
- 1987-10-01 AU AU80712/87A patent/AU603837B2/en not_active Expired
- 1987-10-01 EP EP87906722A patent/EP0318522A1/de active Pending
- 1987-10-01 AT AT87114368T patent/ATE62815T1/de not_active IP Right Cessation
- 1987-10-01 IL IL84055A patent/IL84055A/xx not_active IP Right Cessation
- 1987-10-01 PH PH35872A patent/PH23440A/en unknown
- 1987-10-01 IE IE263387A patent/IE60492B1/en not_active IP Right Cessation
- 1987-10-01 KR KR1019880700606A patent/KR930010585B1/ko not_active Expired - Lifetime
- 1987-10-01 NZ NZ222020A patent/NZ222020A/xx unknown
- 1987-10-01 DE DE8787114368T patent/DE3769568D1/de not_active Expired - Lifetime
- 1987-10-01 ES ES198787114368T patent/ES2038643T3/es not_active Expired - Lifetime
- 1987-10-01 CA CA000548400A patent/CA1294877C/en not_active Expired - Lifetime
- 1987-10-01 WO PCT/US1987/002470 patent/WO1988002257A1/en not_active Ceased
- 1987-10-01 ZA ZA877401A patent/ZA877401B/xx unknown
- 1987-10-01 JP JP62506126A patent/JPH0643317B2/ja not_active Expired - Lifetime
1988
- 1988-05-30 KR KR1019880700606A patent/KR880701555A/ko active Granted
- 1988-05-31 DK DK198802950A patent/DK174790B1/da not_active IP Right Cessation
- 1988-06-01 NO NO882417A patent/NO175350C/no unknown
1989
- 1989-03-30 OA OA59548A patent/OA09034A/xx unknown
- 1989-03-31 FI FI891552A patent/FI100047B/fi not_active IP Right Cessation
1991
- 1991-06-07 GR GR91400764T patent/GR3002086T3/el unknown
1992
- 1992-06-25 MX MX9203395A patent/MX9203395A/es active IP Right Grant
1993
- 1993-09-30 HK HK1025/93A patent/HK102593A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
PH23440A (en)	1989-08-07
KR930010585B1 (ko)	1993-10-30
DK295088D0 (da)	1988-05-31
NO882417D0 (no)	1988-06-01
IE872633L (en)	1988-04-02
ZA877401B (en)	1988-05-25
FI100047B (fi)	1997-09-15
CA1294877C (en)	1992-01-28
FI891552A0 (fi)	1989-03-31
IE60492B1 (en)	1994-07-27
AU603837B2 (en)	1990-11-29
JPH0643317B2 (ja)	1994-06-08
IL84055A0 (en)	1988-03-31
NO882417L (no)	1988-06-01
DK174790B1 (da)	2003-11-17
FI891552L (fi)	1989-03-31
US4808610A (en)	1989-02-28
ES2038643T3 (es)	1993-08-01
DE3769568D1 (de)	1991-05-29
NZ222020A (en)	1990-03-27
OA09034A (en)	1991-03-31
NO175350C (no)	1994-10-05
NO175350B (no)	1994-06-27
EP0262681A1 (de)	1988-04-06
JPH02500976A (ja)	1990-04-05
IL84055A (en)	1991-09-16
WO1988002257A1 (en)	1988-04-07
EP0262681B1 (de)	1991-04-24
KR880701555A (ko)	1988-11-03
MX9203395A (es)	1992-07-01
HK102593A (en)	1993-10-08
EP0318522A1 (de)	1989-06-07
DK295088A (da)	1988-05-31
AU8071287A (en)	1988-04-21
GR3002086T3 (en)	1992-12-30

Legal Events

Date	Code	Title
1992-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties
1992-07-15	EEK	Proclamation as to paragraph 128 patent law
1992-10-15	UEP	Publication of translation of european patent specification
2008-01-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
ATE62815T1 (de)	1991-05-15	Entzuendungshemmende creme.
EG17753A (en)	1991-12-30	Novel pharmacological compounds
DK581185D0 (da)	1985-12-13	Farmaceutisk praeparat indeholdende 13-cis-a-vitaminsyre
MY101784A (en)	1992-01-17	Novel pharmacological compounds
IT8221278A0 (it)	1982-05-14	Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
ZA91115B (en)	1991-09-25	Topical compositions
DE3273193D1 (en)	1986-10-16	Cream base
AU570638B2 (en)	1988-03-24	Corticoid formulations
IT1186754B (it)	1987-12-16	Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8 fenil-10 antrone-9,e procedimento di preparazione dell'ingrediente attivo
AU563760B2 (en)	1987-07-23	Etofenamate formulations
LU81501A1 (fr)	1979-10-31	Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
AU517208B2 (en)	1981-07-16	Animal "pled ingredient
IL58815A0 (en)	1980-02-29	Cyclododecane derivatives,their preparation and pharmaceutical compositions containing them
NZ189211A (en)	1980-11-14	1,4-cyclohexadiene carboxylic acid derivatives and pharmaceutical compositions
IT1201431B (it)	1989-02-02	Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo acetil -10 triacetossi-1,8,9 antracene
IT7920770A0 (it)	1979-03-06	Composizioni dermatologiche a basedi derivati dell'acido mercaptopropionammido-acetico.